Reactivity of FDA-approved anti-D reagents with partial D red blood cells
, und
01. Mai 2020
Über diesen Artikel
Online veröffentlicht: 01. Mai 2020
Seitenbereich: 146 - 148
DOI: https://doi.org/10.21307/immunohematology-2019-409
Schlüsselwörter
© 2005 W.J. Judd, et al., published by Sciendo
Judd, W.J.
Department of Pathology, University of MichiganAnn Arbor, MI, United States
Moulds, M.
Immunohematology Reference Laboratory ImmucorGammaHouston, TX, United States
Schlanser, G.
Immunohematology Reference Laboratory ImmucorGammaHouston, TX, United States